XML 46 R30.htm IDEA: XBRL DOCUMENT v3.20.4
Discontinued Operations (Tables)
12 Months Ended
Dec. 31, 2020
Discontinued Operations  
Summary of discontinued operations

December 31, 

2019

    

Assets Held For Sale

Cash and cash equivalents ($95,202 restricted)

$

209,497

Accounts receivable, net

 

209,496

Short-term and long-term investments ($243,496 restricted)

 

243,496

Property and equipment, net

 

6,710

Goodwill

 

211,735

Other intangible assets, net

 

85,669

Other current and long-term assets ($2,387 restricted)

32,386

Total Assets Held For Sale

998,989

Less: current portion

663,276

Total Assets Held For Sale, Less Current Portion

$

335,713

Liabilities Held For Sale

Accounts payable

$

4,625

Accrued liabilities

 

92,170

Medical claims payable

 

281,419

Other medical liabilities

 

31,769

Deferred income taxes

15,063

Tax contingencies

 

5,388

Deferred credits and other long-term liabilities

 

16,850

Total Liabilities Held For Sale

 

447,284

Less: current portion

 

409,983

Total Liabilities Held For Sale, Less Current Portion

$

37,301

    

Year Ended

December 31, 

    

2018

    

2019

    

2020

Managed care and other revenue

$

2,529,386

$

2,757,511

$

2,924,014

Costs and expenses:

Cost of care

 

2,207,721

 

2,397,007

 

2,377,847

Direct service costs and other operating expenses (1)(2)(3)

 

300,696

 

292,351

 

360,783

Depreciation and amortization

 

20,376

 

21,142

 

20,358

Interest expense

 

216

 

285

 

89

Interest and other income

 

(9,184)

 

(12,332)

 

(5,464)

Gain on sale

(348,145)

Total costs and expenses

 

2,519,825

 

2,698,453

 

2,405,468

Income from discontinued operation before income taxes

 

9,561

 

59,058

 

518,546

Provision for income taxes

 

7,556

 

15,753

 

140,257

Net income from discontinued operations

$

2,005

$

43,305

$

378,289

(1)Includes stock compensation expense of $536, $828 and $278 for the years ended December 31, 2018, 2019 and 2020 respectively.
(2)Includes changes in fair value of contingent consideration of $199 and $(2,124) for the years ended December 31, 2018 and 2019, respectively.
(3)Includes divestiture related expenses of $9,379 for the year ended December 31, 2020.